drugset / Trial / NCT00411619

Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

NCT00411619

NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate the safety and potential side effects of everolimus (an experimental drug) on a person with Tuberous Sclerosis Complex who also has been diagnosed with a brain tumor (astrocytoma) The hypothesis is that the drug will cause the tumor size to decrease, and may have beneficial activity separate from effects on tumors in patients.

Timeline

Start
2007-01
Primary completion
2014-01
Completion
2014-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Everolimus Small molecule 3 mg/m2 Oral